San Diego-based mostly Viking Therapeutics marked by itself as a significant competitor inside the weight loss drug current market in February following revealing promising data from a mid-phase demo of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when specified for a weekly injection As well as in Mar